2.5mg semaglutide to tirzepatide vs Semaglutide: What's the Difference? How Many Units Is 2.5

[1] GLP-1 receptor agonists (e.g., semaglutide/Wegovy, liraglutide/Saxenda): These injectable medications mimic the glucagon-like peptide-1 hormone, suppressing appetite and slowing gastric emptying

Heres what you need to know: Manufacturer Savings Programs Novo Nordisk (makes Wegovy, Ozempic, and Saxenda) offers savings cards that can reduce copays to as low as $25 per month for eligible patients with commercial insurance These programs have specific eligibility requirements and typically exclude Medicare/Medicaid patients Your doctors office can help you determine eligibility and apply Prior Authorization Tips If your insurance requires prior authorization, be patient

By activating both pathways, a dual agonist can produce a more powerful effect on appetite suppression and metabolic function than a GLP-1 agonist alone

It comes in two FDA-approved forms, both weekly injections: Mounjaro: type 2 diabetes (2.5 to 15 mg) Zepbound: obesity (2.5 to 15 mg) and moderate-to-severe obstructive sleep apnea in adults with obesity (approved December 2024) No oral tirzepatide exists as of April 2026